2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$13.86$0.00 (0.00%)
Price as of Jul 13, 2026 6:18 PM EDT- $948.7MMarket Cap
- 246.38%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$13.86$0.00 (0.00%)
DSGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.86 | ||
Change | -$1.33 (-8.79%) | ||
Open | $14.96 | ||
High | $15.20 | ||
Low | $13.58 | ||
Previous Close | $15.19 | ||
Volume | 654,659 | ||
30-Day Average Volume | 1,057,468 | ||
1-Week Change | -6.70% | ||
1-Month Change | 26.30% | ||
1-Year Change | 246.38% | ||
3-Year Change | 100.80% | ||
5-Year Change | -26.38% | ||
Fundamentals | |||
Shares Outstanding | 62.5M | ||
Total Assets | $230.4M | ||
Market Cap | $948.7M | ||
Enterprise Value | $936.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$16.4M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.5M | ||
Net Working Capital | $216.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -54 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -52 | ||
PEG | 8 | ||
Price/Free Cash Flow | -58 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue